{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:16:34Z","timestamp":1790270194390,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T00:00:00Z","timestamp":1573344000000},"content-version":"vor","delay-in-days":1623,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/annonc\/mdv133","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T01:04:06Z","timestamp":1428627846000},"page":"1194-1200","source":"Crossref","is-referenced-by-count":88,"title":["A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"G.","family":"Deplanque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hebbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Melichar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nowara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Moy\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Piquemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Acin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv133_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-8-82","article-title":"Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer","volume":"8","author":"Heinemann","year":"2008","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1093\/annonc\/mdv133_bb0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1093\/annonc\/mdv133_bb0020","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv133_bb0025","doi-asserted-by":"crossref","first-page":"e9430","DOI":"10.1371\/journal.pone.0009430","article-title":"Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model","volume":"5","author":"Humbert","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1093\/annonc\/mdv133_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00280-010-1299-8","article-title":"Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer","volume":"66","author":"Mitry","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3B","key":"10.1093\/annonc\/mdv133_bb0035","first-page":"2267","article-title":"Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment","volume":"23","author":"Zelvyte","year":"2003","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1093\/annonc\/mdv133_bb0040","doi-asserted-by":"crossref","first-page":"e40157","DOI":"10.1371\/journal.pone.0040157","article-title":"A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers","volume":"7","author":"Winter","year":"2012","journal-title":"PLoS One"},{"issue":"22","key":"10.1093\/annonc\/mdv133_bb0045","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1158\/1078-0432.CCR-11-0607","article-title":"Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma","volume":"17","author":"Chang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdv133_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphys.2013.00210","article-title":"Immune infiltrates as predictive markers of survival in pancreatic cancer patients","volume":"4","author":"Protti","year":"2013","journal-title":"Front Physiol"},{"issue":"9","key":"10.1093\/annonc\/mdv133_bb0055","doi-asserted-by":"crossref","first-page":"e7258","DOI":"10.1371\/journal.pone.0007258","article-title":"Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT","volume":"4","author":"Dubreuil","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1093\/annonc\/mdv133_bb0060","doi-asserted-by":"crossref","first-page":"e60529","DOI":"10.1371\/journal.pone.0060529","article-title":"Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis","volume":"8","author":"Demir","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1093\/annonc\/mdv133_bb0065","first-page":"19","article-title":"Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation","volume":"1796","author":"Maltby","year":"2009","journal-title":"Biochim Biophys Acta"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/6\/1194\/16699942\/mdv133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:49:14Z","timestamp":1624520954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419318083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0923753419318083"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv133","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}